Why Exhibit?

The extension of the CPhI franchise into India in December 2006 reflects continuing growth in the stature of this country on the worldwide pharmaceutical manufacturing stage. Already a major exporter of FDA compliant APIs, and having gained a reputation for its ability to run successful clinical trials, India has proven itself as an emerging market with both experience and the appropriate expertise.

Most importantly, India offers potential investors a highly qualified workforce used to working to GMP standards. A long history of chemical manufacturing in the country has already allowed it to become a major manufacturer of generic drugs. Its adoption of patent agreements in 2005 has opened the way for expansion in the manufacture of drugs for the major pharmaceutical companies. In fact, companies such as Merck, GSK, Pfizer, Roche and Bristol Myers Squibb have already established manufacturing facilities and major hubs in the country, paving the way for other organisations to join them.

The combination of these factors plus an excellent compliance record, the potential for significant cost savings and the ability to bring new manufacturing facilities on line quickly makes India a very desirable place to bring your business.

Click here to view stand options and costs.
Click here to book a stand.